Biogen Q3 Adj. EPS $4.81 Beats $3.88 Estimate, Sales $2.534B Beat $2.339B Estimate

Author: Benzinga Newsdesk | October 30, 2025 05:52am
Biogen (NASDAQ:BIIB) reported quarterly earnings of $4.81 per share which beat the analyst consensus estimate of $3.88 by 23.91 percent. This is a 17.89 percent increase over earnings of $4.08 per share from the same period last year. The company reported quarterly sales of $2.534 billion which beat the analyst consensus estimate of $2.339 billion by 8.34 percent. This is a 2.76 percent increase over sales of $2.466 billion the same period last year.

Posted In: BIIB